These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25218950)

  • 1. Meeting report: 27th International conference on antiviral research, in Raleigh, NC, USA.
    Vere Hodge RA
    Antiviral Res; 2014 Nov; 111():143-53. PubMed ID: 25218950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting report: 28th International Conference on Antiviral Research in Rome, Italy.
    Vere Hodge RA
    Antiviral Res; 2015 Nov; 123():172-87. PubMed ID: 26431686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting report: 26th International Conference on Antiviral Research.
    Vere Hodge RA
    Antiviral Res; 2013 Oct; 100(1):276-85. PubMed ID: 23973733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting report: 29th International Conference on Antiviral Research in La Jolla, CA, USA.
    Vere Hodge RA
    Antiviral Res; 2017 Jan; 137():23-40. PubMed ID: 27815125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highlights of the 30th International Conference on Antiviral Research.
    Andrei G; Carter K; Janeba Z; Sampath A; Schang LM; Tarbet EB; Vere Hodge RA; Bray M; Esté JA
    Antiviral Res; 2017 Sep; 145():184-196. PubMed ID: 28774800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA.
    Vere Hodge RA
    Antivir Chem Chemother; 2018; 26():2040206618783924. PubMed ID: 29954186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scientific report: highlights of 24th ICAR, 8-11 May 2011, Sofia, Bulgaria.
    Vere Hodge A
    Antivir Chem Chemother; 2011 Oct; 22(2):75-85. PubMed ID: 21984687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human viral diseases: what is next for antiviral drug discovery?
    De Clercq E
    Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
    De Clercq E
    Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting report: 32nd International Conference on Antiviral Research.
    Tramontano E; Tarbet B; Spengler JR; Seley-Radtke K; Meier C; Jordan R; Janeba Z; Gowen B; Gentry B; Esté JA; Bray M; Andrei G; Schang LM;
    Antiviral Res; 2019 Sep; 169():104550. PubMed ID: 31302149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in antiviral nucleoside and nucleotide therapeutics.
    Simons C; Wu Q; Htar TT
    Curr Top Med Chem; 2005; 5(13):1191-203. PubMed ID: 16305526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
    Nijhuis M; van Maarseveen NM; Boucher CA
    Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.
    Wesdorp DJ; Knoester M; Braat AE; Coenraad MJ; Vossen AC; Claas EC; van Hoek B
    J Clin Virol; 2013 Sep; 58(1):67-73. PubMed ID: 23880162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of NTCP-inhibitor myrcludex B.
    Cheng D; Han B; Zhang W; Wu W
    J Viral Hepat; 2021 Jun; 28(6):852-858. PubMed ID: 33599010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday.
    Li G; Yue T; Zhang P; Gu W; Gao LJ; Tan L
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33572409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Potential of Spirooxindoles as Antiviral Agents.
    Ye N; Chen H; Wold EA; Shi PY; Zhou J
    ACS Infect Dis; 2016 Jun; 2(6):382-92. PubMed ID: 27627626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.
    Hostetler KY
    Antiviral Res; 2009 May; 82(2):A84-98. PubMed ID: 19425198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cutting-edge view on the current state of antiviral drug development.
    De Clercq E
    Med Res Rev; 2013 Nov; 33(6):1249-77. PubMed ID: 23495004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge.
    Xu X; Zhang QY; Chu XY; Quan Y; Lv BM; Zhang HY
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aiming for cure in HBV and HDV infection.
    Petersen J; Thompson AJ; Levrero M
    J Hepatol; 2016 Oct; 65(4):835-848. PubMed ID: 27270043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.